Diagnostic and therapeutic considerations in Turner syndrome

키워드

참고문헌 (51)

1. Turner HH, "A syndrome of infantilism, congenital webbed neck, and cubitus valus", Endocrinology, 23, pp.566~574 (1938)
2. Ford CE, "A sex-chromosome anomaly in a case of gonadal dysgenesis (Turner's syndrome)", Lancet, 1, pp.711~713 (1959)
3. Lemli L, "The XO syndrome. A study of the differentiated phenotype in 25 patients", J Pediatr, 63, pp.577~588 (1963)
4. Levitsky LL, "Turner syndrome: update on biology and management across the life span", Curr Opin Endocrinol Diabetes Obes, 22, pp.65~72 (2015)
5. Mohamed S, "Mode of initial presentation and chromosomal abnormalities in Irish patients with Turner syndrome: a single-centre experience", J Pediatr Endocrinol Metab, 28, pp.1215~1218 (2015)
6. Wonkam A, "Features of Turner syndrome among a group of Cameroonian patients", Int J Gynaecol Obstet, 129, pp.264~266 (2015)
7. Miguel-Neto J, "New approach to phenotypic variability and karyotype-phenotype correlation in Turner syndrome", J Pediatr Endocrinol Metab, 29, pp.475~479 (2016)
8. Sari E, "Anthropometric findings from birth to adulthood and their relation with karyotpye distribution in Turkish girls with Turner syndrome", Am J Med Genet A, 170A, pp.942~948 (2016)
9. Saari A, "Screening of turner syndrome with novel auxological criteria facilitates early diagnosis", J Clin Endocrinol Metab, 97, pp.E2125~E2132 (2012)
10. Mercer CL, "Detailed clinical and molecular study of 20 females with Xq deletions with special reference to menstruation and fertility", Eur J Med Genet, 56, pp.1~6 (2013)
11. Mazloom AR, "Noninvasive prenatal detection of sex chromosomal aneuploidies by sequencing circulating cell-free DNA from maternal plasma", Prenat Diagn, 33, pp.591~597 (2013)
12. Liang D, "Non-invasive prenatal testing of fetal whole chromosome aneuploidy by massively parallel sequencing", Prenat Diagn, 33, pp.409~415 (2013)
13. Castronovo C, "Gene dosage as a relevant mechanism contributing to the determination of ovarian function in Turner syndrome", Hum Reprod, 29, pp.368~379 (2014)
14. Corrêa SC, "Neonatal detection of Turner syndrome by real-time PCR gene quantification of the ARSE and MAGEH1 genes", Genet Mol Res, 13, pp.9068~9076 (2014)
15. Prakash S, "Single-nucleotide polymorphism array genotyping is equivalent to metaphase cytogenetics for diagnosis of Turner syndrome", Genet Med, 16, pp.53~59 (2014)
16. Hook EB, "Turner syndrome revisited: review of new data supports the hypothesis that all viable 45,X cases are cryptic mosaics with a rescue cell line, implying an origin by mitotic loss", Hum Genet, 133, pp.417~424 (2014)
17. Stanescu DE, "50 Years ago in The Journal of Pediatrics: the XO syndrome: a study of the differential phenotype in 25 patients", J Pediatr, 163, pp.1044~ (2013)
18. Blum WF, "GH treatment to final height produces similar height gains in patients with SHOX deficiency and Turner syndrome: results of a multicenter trial", J Clin Endocrinol Metab, 98, pp.E1383~E1392 (2013)
19. Wasniewska M, "Adult height in girls with Turner syndrome treated from before 6 years of age with a fixed per kilogram GH dose", Eur J Endocrinol, 169, pp.439~443 (2013)
20. Legro RS, "Turner syndrome: new insights into an old disorder", Fertil Steril, 98, pp.773~774 (2012)
21. Lyon AJ, "Growth curve for girls with Turner syndrome", Arch Dis Child, 60, pp.932~935 (1985)
22. Saari A, "Multiethnic WHO growth charts may not be optimal in the screening of disorders affecting height: Turner syndrome as a model", JAMA Pediatr, 167, pp.194~195 (2013)
23. Bertapelli F, "Growth curves for girls with Turner syndrome", Biomed Res Int, 2014, pp.687978~ (2014)
24. Clement-Jones M, "The short stature homeobox gene SHOX is involved in skeletal abnormalities in Turner syndrome", Hum Mol Genet, 9, pp.695~702 (2000)
25. Fiot E, "X-chromosome gene dosage as a determinant of impaired pre and postnatal growth and adult height in Turner syndrome", Eur J Endocrinol, 174, pp.281~288 (2016)
26. Malaquias AC, "The sitting height", height ratio for age in healthy and short individuals and its potential role in selecting short children for SHOX analysis, 2013, pp.80, 449~456
27. Tai S, "An observational study of the effectiveness and safety of growth hormone (Humatrope(®)) treatment in Japanese children with growth hormone deficiency or Turner syndrome", Endocr J, 60, pp.57~64 (2013)
28. Bettendorf M, "Height gain in Ullrich-Turner syndrome after early and late growth hormone treatment start: results from a large retrospective German study and potential basis for an individualized treatment approach", Horm Res Paediatr, 80, pp.356~362 (2013)
29. Clayton P, "A pharmacogenomic approach to the treatment of children with GH deficiency or Turner syndrome", Eur J Endocrinol, 169, pp.277~289 (2013)
30. Stevens A, "Validating genetic markers of response to recombinant human growth hormone in children with growth hormone deficiency and Turner syndrome: the PREDICT validation study", Eur J Endocrinol, 175, pp.633~643 (2016)
31. Braz AF, "Genetic predictors of long-term response to growth hormone (GH) therapy in children with GH deficiency and Turner syndrome: the influence of a SOCS2 polymorphism", J Clin Endocrinol Metab, 99, pp.E1808~E13 (2014)
32. Schrier L, "Comparison of body surface area versus weight-based growth hormone dosing for girls with Turner syndrome", Horm Res Paediatr, 81, pp.319~330 (2014)
33. Juloski J, "Growth hormone positive effects on craniofacial complex in Turner syndrome", Arch Oral Biol, 71, pp.10~15 (2016)
34. Soares MQ, "Lichen planus-like drug reaction associated with recombinant human growth hormone therapy in a child patient with Turner syndrome", Dermatol Online J, 22(3) (2016)
35. Freriks K, "Long-term effects of previous oxandrolone treatment in adult women with Turner syndrome", Eur J Endocrinol, 168, pp.91~99 (2012)
36. Sas TC, "Safety and efficacy of oxandrolone in growth hormone-treated girls with Turner syndrome: evidence from recent studies and recommendations for use", Horm Res Paediatr, 81, pp.289~297 (2014)
37. Xiong H, "Therapeutic effects of growth hormone combined with low-dose stanozolol on growth velocity and final height of girls with Turner syndrome", Clin Endocrinol (Oxf ), 83, pp.223~228 (2015)
38. Menke LA, "Efficacy and safety of oxandrolone in growth hormone-treated girls with turner syndrome", J Clin Endocrinol Metab, 95, pp.1151~1160 (2010)
39. Visser JA, "Anti-Müllerian hormone levels in girls and adolescents with Turner syndrome are related to karyotype, pubertal development and growth hormone treatment", Hum Reprod, 28, pp.1899~1907 (2013)
40. Ankarberg-Lindgren C, "Physiological estrogen replacement therapy for puberty induction in girls: a clinical observational study", Horm Res Paediatr, 81, pp.239~244 (2014)
41. Quigley CA, "Effects of low-dose estrogen replacement during childhood on pubertal development and gonadotropin concentrations in patients with Turner syndrome: results of a randomized, double-blind, placebo-controlled clinical trial", J Clin Endocrinol Metab, 99, pp.E1754~E1764 (2014)
42. Gravholt CH, "Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting", Eur J Endocrinol, 177, pp.G1~G70 (2017)
43. Torres-Santiago L, "Metabolic effects of oral versus transdermal 17β-estradiol (E₂): a randomized clinical trial in girls with Turner syndrome", J Clin Endocrinol Metab, 98, pp.2716~2724 (2013)
44. Sweetland S, "Venous thromboembolism risk in relation to use of different types of postmenopausal hormone therapy in a large prospective study", J Thromb Haemost, 10, pp.2277~2286 (2012)
45. Labarta JI, "Individualised vs fixed dose of oral 17β-oestradiol for induction of puberty in girls with Turner syndrome: an open-randomised parallel trial", Eur J Endocrinol, 167, pp.523~529 (2012)
46. Cleemann L, "Dosage of estradiol, bone and body composition in Turner syndrome: a 5-year randomized controlled clinical trial", Eur J Endocrinol, 176, pp.233~242 (2017)
47. Carel JC, "Self-esteem and social adjustment in young women with Turner syndrome--influence of pubertal management and sexuality: population-based cohort study", J Clin Endocrinol Metab, 91, pp.2972~2979 (2006)
48. Rosenfield RL, "Commentary: launch of a quality improvement network for evidence-based management of uncommon pediatric endocrine disorders: Turner syndrome as a prototype", J Clin Endocrinol Metab, 100, pp.1234~1236 (2015)
49. Gravholt CH, "Morbidity in Turner syndrome", J Clin Epidemiol, 51, pp.147~158 (1998)
50. Hasle H, "Occurrence of cancer in women with Turner syndrome", Br J Cancer, 73, pp.1156~1159 (1996)
51. Bannink EM, "Quality of life after growth hormone therapy and induced puberty in women with Turner syndrome", J Pediatr, 148, pp.95~101 (2006)

관련 논문AI추천